THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEY

Marmarali, B.Ozdemir, O.Bozkurt, K.Demir, M.Ince, B.Kultursay, H.Ongen, G.2024-06-122024-06-1220131098-3015https://doi.org/10.1016/j.jval.2013.03.1480https://hdl.handle.net/20.500.14551/25647[Abstract Not Available]en10.1016/j.jval.2013.03.1480info:eu-repo/semantics/openAccess[No Keywords]THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEYConference Object163A285A285Q1WOS:000318916402439